You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
7 October 2019
Nestlé Skin Health has reverted to its original name of Galderma and gained a new team following the recent takeover by a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).
4 October 2019
Nestlé has completed the sale of its Skin Health business for CHF10.2 billion (USD10.2 billion) to a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).
16 May 2019
Nestlé has entered into exclusive negotiations on the sale of its Skin Health business for CHF10.2 billion (USD10.1 billion) to a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).
10 May 2019
Galderma is seeking to switch two medicines containing benzoyl peroxide – Acnecide Face Gel and Acnecide Face Wash – from pharmacy (P) to general-sale list (GSL) status in the UK.
24 April 2019
Nestlé expects to complete the strategic review of its Skin Health business in "mid-2019".
18 February 2019
The strategic review of Nestlé Skin Health has attracted "very strong interest", with people lining up to be part of the process, according to Nestlé's chief executive officer Mark Schneider.
25 January 2019
Nestlé Skin Health has opened an office in Malaysia, as media reports suggest a number of private-equity firms are interested in making a bid for the business.
23 October 2018
News in brief from Nestlé, Abbott, DKSH and Keystone Laboratories.
20 September 2018
Nestlé is exploring strategic options for its Skin Health business, which markets a range of medical and consumer healthcare products. The Swiss company said "future growth opportunities of Nestlé Skin Health lie increasingly outside the group's strategic scope".